Time from referral to end of primary investigation ≤ 28 days | Time from end of primary investigation to first day of treatment ≤ 14 days | Time from referral to first day of treatment ≤ 42 days | |
---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Transfer (yes vs no) | 0.82 (0.74;0.92a) | 0.66 (0.61;0.72a) | 0.63 (0.58;0.69a) |
Age (high vs low) | 0.85 (0.76;0.94a) | 0.91 (0.83;0.99a) | 0.78 (0.71;0.86a) |
Sex (males vs female) | 0.92 (0.83;1.03) | 1.05 (0.96;1.14) | 1.02 (0.93;1.12) |
Stage (high vs low) | 2.08 (1.84;2.37a) | 1.17 (1.05;1.30a) | 2.02 (1.81;2.25a) |
Treatment (cur vs pal) | 1.68 (1.47;1.91a) | 0.72 (0.65;0.81a) | 1.23 (1.10;1.38a) |
CCI (increasing) | 0.83 (0.77;0.91a) | 0.91 (0.85;0.97a) | 0.84 (0.78;0.90a) |
ECOG (increasing) | 1.08 (1.03;1.14a) | 0.94 (0.90;0.98a) | 1.00 (0.96;1.05) |
FEV1 (increasing) | 0.94 (0.88;1.00) | 1.09 (1.04;1.15a) | 1.03 (0.98;1.09) |
Year (increasing) | 0.98 (0.94;1.01) | 1.29 (1.26;1.33a) | 1.17 (1.05;1.20a) |